摘要: Triamcinolone is a commonly used synthetic corticosteroid that has recently been tested in large clinical trial for chronic obstructive pulmonary disease and shown to have some benefits. To our knowledge, there are no reviews of the pharmacotherapy triamcinolone. This review brief overview pharmacology triamcinolone, followed by discussion trials with treatment respiratory inflammation, rheumatoid arthritis variety other inflammatory conditions.
informapharmascience.com参考文章(54)
Timothy J. Drehmer, Matthew T. Carpenter, William E. Venanzi, David R. Finger, Mark J. Jarek, Jeff A. Alloway, Mark D. Harris, Alan R. Erickson, Douglas W. Roane, Prospective use of intramuscular triamcinolone acetonide in pseudogout The Journal of Rheumatology. ,vol. 24, pp. 1168- 1170 ,(1997)
DO Sandra M. Gawchik, Janet Lim, Comparison of intranasal triamcinolone acetonide with oral loratadine in the treatment of seasonal ragweed-induced allergic rhinitis. The American Journal of Managed Care. ,vol. 3, pp. 1052- ,(1997)
Huber F, Findlay S, Garcia J, Huang L, Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Annals of allergy. ,vol. 68, pp. 228- 232 ,(1992)
O P Sharma, L Navarro, L Mancinelli, Intramuscular high-dose triamcinolone acetonide in the treatment of severe chronic asthma. Western Journal of Medicine. ,vol. 167, pp. 322- 329 ,(1997)
Christine A. Sorkness, Craig LaForce, William Storms, William R. Lincourt, Lisa Edwards, Paula R. Rogenes, Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. Clinical Therapeutics. ,vol. 21, pp. 353- 367 ,(1999) , 10.1016/S0149-2918(00)88292-2
F. Laliberté, J. Bousquet, M. F. Laliberté, S. Lécart, J. M. Klossec, N. Mounedji, , Clinical and pathologic methods to assess the long‐term safety of nasal corticosteroids Allergy. ,vol. 55, pp. 718- 722 ,(2000) , 10.1034/J.1398-9995.2000.00649.X
Joe W Ramsdell, Lloyd Fish, David Graft, Nancy Higgins, Mani Kavuru, Warren Pleskow, Donald Banerji, A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma. Annals of Allergy Asthma & Immunology. ,vol. 80, pp. 385- 390 ,(1998) , 10.1016/S1081-1206(10)62988-2
John Condemi, Richard Schulz, Janet Lim, Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. Annals of Allergy Asthma & Immunology. ,vol. 84, pp. 533- 538 ,(2000) , 10.1016/S1081-1206(10)62518-5
David I. Bernstein, Robert Cohen, Elliot Ginchansky, Andrew J. Pedinoff, David G. Tinkelman, John A. Winder, Clinical aspects of allergic disease Journal of Allergy and Clinical Immunology. ,vol. 101, pp. 433- 438 ,(1998) , 10.1016/S0091-6749(98)70349-5
R. Rosenthal, W. Berger, E. Bronsky, R. Dockhom, P. Korenblat, K. Lampl, W. Lumry, S. Pollard, G. Raphael, C. Rohr, G. Shapiro, M. Valentine, A. Wanderer, L. Fleming, N. LaVallee, M. Stepanians, J. Karafilidis, J. Shilstone, Elliot Ellis, Tri-nasal triamcinolone acetonide nasal spray 200 and 400 μg qd versus placebo and nasacort triamcinolone acetonide nasal aerosol 440 μg qd in patients suffering from seasonal allergic rhinitis during the grass season American Journal of Rhinology. ,vol. 12, pp. 427- 433 ,(1998) , 10.2500/105065898780707991